Home Featured Page 197

Featured

Latest

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts Hold on GH Research’s 5-MeO-DMT IND; Compass Details Pivotal PTSD Trial Design; Cybin...

Manvir Singh: Shamanism, the Timeless Religion

2025 Year in Review: Future(s) & Open Questions (Video)

2025 Year in Review: 10 Standout Stories in Psychedelics

MHRA Guidance on the use of Real-World Data in Clinical Studies...

MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC

Psychedelic Bulletin: First Look at Field Trip’s FT-104 Molecule; MindMed Trial...

PT280 – Danny Peterson – Psychedelics, Religion, and Freedom

Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge...

MindMed Announces Transitions to Management Team

COMPASS Patent Challenge Targets Crystallography Errors

PT279 – Joe Zap & Kevin Whalen – Cannabis Acceptance, Conspiratorial...

PTSF90 – Colorado’s Natural Medicine Healing Act and Guidelines for Emergency...

Numinus Wellness Commends Health Canada on Special Access Programme Amendments to...

1...196197198...305 Page 197 of 305

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts...

Manvir Singh: Shamanism, the Timeless Religion

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts Hold on GH Research’s 5-MeO-DMT IND; Compass Details Pivotal PTSD Trial Design; Cybin...

Manvir Singh: Shamanism, the Timeless Religion

2025 Year in Review: Future(s) & Open Questions (Video)

2025 Year in Review: 10 Standout Stories in Psychedelics

MHRA Guidance on the use of Real-World Data in Clinical Studies...

MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC

Psychedelic Bulletin: First Look at Field Trip’s FT-104 Molecule; MindMed Trial...

PT280 – Danny Peterson – Psychedelics, Religion, and Freedom

Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge...

MindMed Announces Transitions to Management Team

COMPASS Patent Challenge Targets Crystallography Errors

PT279 – Joe Zap & Kevin Whalen – Cannabis Acceptance, Conspiratorial...

PTSF90 – Colorado’s Natural Medicine Healing Act and Guidelines for Emergency...

Numinus Wellness Commends Health Canada on Special Access Programme Amendments to...

EDITOR PICKS

Psychedelic Medicine at the Edge of Science and Spirit

Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts...

Manvir Singh: Shamanism, the Timeless Religion

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY